Scarica l'app Stockscreener
1.145
1.73%
-0.015
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.16
Aprire:
$1.18
Volume 24 ore:
311.05K
Relative Volume:
0.17
Capitalizzazione di mercato:
$208.06M
Reddito:
$137.74M
Utile/perdita netta:
$-27.97M
Rapporto P/E:
-7.1563
EPS:
-0.16
Flusso di cassa netto:
$-9.61M
1 W Prestazione:
-3.40%
1M Prestazione:
-13.64%
6M Prestazione:
-50.65%
1 anno Prestazione:
-35.96%
Intervallo 1D:
$1.13
$1.19
Intervallo di 1 settimana:
$1.13
$1.22
Portata 52W:
$1.04
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
Nome
Heron Therapeutics Inc
Settore
Industria
Telefono
(858) 251-4400
Indirizzo
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Confronta HRTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.135 | 212.64M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.72 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.82 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.12 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-09 | Iniziato | H.C. Wainwright | Buy |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-23 | Iniziato | CapitalOne | Overweight |
| 2024-03-13 | Reiterato | Needham | Buy |
| 2020-05-27 | Iniziato | Guggenheim | Buy |
| 2020-02-20 | Reiterato | Needham | Buy |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-04-05 | Iniziato | Evercore ISI | Outperform |
| 2018-03-19 | Reiterato | Mizuho | Buy |
| 2018-03-01 | Reiterato | Needham | Buy |
| 2018-01-03 | Iniziato | Leerink Partners | Outperform |
| 2017-09-27 | Iniziato | Northland Capital | Outperform |
| 2017-02-27 | Iniziato | Needham | Buy |
| 2016-10-26 | Iniziato | Aegis Capital | Buy |
| 2016-09-06 | Ripresa | Lake Street | Buy |
| 2016-05-03 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-12-10 | Iniziato | Lake Street | Buy |
| 2015-09-23 | Reiterato | Leerink Partners | Outperform |
| 2015-09-02 | Iniziato | BofA/Merrill | Buy |
| 2015-08-03 | Reiterato | Brean Capital | Buy |
| 2015-06-30 | Reiterato | JMP Securities | Mkt Outperform |
| 2015-06-19 | Reiterato | Leerink Partners | Outperform |
| 2014-08-07 | Iniziato | Noble Financial | Buy |
Mostra tutto
Heron Therapeutics Inc Borsa (HRTX) Ultime notizie
Ranking Heron Therapeutics Inc. among high performing stocks via toolsJuly 2025 Price Swings & Verified Entry Point Signals - newser.com
Heron Therapeutics Inc. stock prediction for this week2025 Historical Comparison & Consistent Growth Stock Picks - newser.com
Why Heron Therapeutics Inc. (AXD2) stock could rally strongly2025 Performance Recap & Accurate Entry and Exit Point Alerts - newser.com
Can trapped investors hope for a rebound in Heron Therapeutics Inc.2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Will Heron Therapeutics Inc. stock attract more institutional investorsInsider Selling & Reliable Breakout Forecasts - newser.com
Tools to monitor Heron Therapeutics Inc. recovery probabilityWeekly Gains Report & Risk Controlled Swing Alerts - newser.com
Should you wait for a breakout in Heron Therapeutics Inc.Portfolio Return Report & Entry and Exit Point Strategies - newser.com
Sentiment analysis tools applied to Heron Therapeutics Inc.2025 Price Targets & Risk Controlled Daily Plans - newser.com
Is Heron Therapeutics Inc. (AXD2) stock inflation resilient2025 Top Gainers & Reliable Volume Spike Trade Alerts - newser.com
Heron Therapeutics Inc. stock daily chart insightsWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com
Can Heron Therapeutics Inc. recover in the next quarterJuly 2025 News Drivers & Fast Entry Momentum Alerts - newser.com
Heron Therapeutics Inc. stock chart pattern explainedJuly 2025 Movers & Safe Capital Growth Tips - newser.com
What MACD and RSI say about Heron Therapeutics Inc.Weekly Trade Report & Free Safe Capital Growth Stock Tips - newser.com
Developing predictive dashboards with Heron Therapeutics Inc. dataTrade Ideas & Verified Technical Signals - newser.com
Can Heron Therapeutics Inc. stock weather global recessionJuly 2025 Decliners & Verified Momentum Stock Ideas - newser.com
Detecting price anomalies in Heron Therapeutics Inc. with AI2025 Market WrapUp & Safe Entry Point Identification - newser.com
Will Heron Therapeutics Inc. stock outperform Nasdaq indexTrade Entry Report & Fast Moving Trade Plans - newser.com
Why Heron Therapeutics Inc. (AXD2) stock attracts wealthy investorsJobs Report & Growth Oriented Trading Recommendations - newser.com
Heron Therapeutics Appoints Thomas Cusack to Board - The Globe and Mail
Can Heron Therapeutics Inc. (AXD2) stock deliver consistent EPS growthQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
Published on: 2025-10-30 01:17:43 - newser.com
Heron Therapeutics, Inc. Appoints Thomas Cusack to Board of Directors - Quiver Quantitative
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors - GlobeNewswire
Heron (NASDAQ: HRTX) names Thomas Cusack to board; ex-Starboard MD at $9B fund - Stock Titan
Heron Therapeutics (HRTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Heron Therapeutics Inc Azioni (HRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Heron Therapeutics Inc Azioni (HRTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Morgan Adam | Director |
Aug 08 '25 |
Buy |
1.50 |
1,766,546 |
2,649,819 |
8,753,290 |
0.21%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):